A phase I study of ispinesib, a kinesin spindle protein...

Investigational New Drugs 2011 / 06 Vol. 29; Iss. 3

A phase I study of ispinesib, a kinesin spindle protein inhibitor, administered weekly for three consecutive weeks of a 28-day cycle in patients with solid tumors

Howard A. Burris, Suzanne F. Jones, Daphne D. Williams, Steven J. Kathman, Jeffrey P. Hodge, Lini Pandite, Peter T. C. Ho, Scott A. Boerner, Patricia LoRusso
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
29
Language:
english
Pages:
6
DOI:
10.1007/s10637-009-9374-x
Date:
June, 2011
File:
PDF, 167 KB
english, 2011
Conversion to is in progress
Conversion to is failed